These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11320668)

  • 1. Bisimidazoacridones induce a potent cytostatic effect in colon tumor cells that sensitizes them to killing by UCN-01.
    Cholody WM; Kosakowska-Cholody T; Michejda CJ
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):241-9. PubMed ID: 11320668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of bisimidazoacridones, new drugs with potent, selective activity against colon cancer.
    Hernandez L; Cholody WM; Hudson EA; Resau JH; Pauly G; Michejda CJ
    Cancer Res; 1995 Jun; 55(11):2338-45. PubMed ID: 7757985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
    Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
    J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA.
    Jaiswal AS; Multani AS; Pathak S; Narayan S
    Mol Cancer; 2004 Jan; 3():3. PubMed ID: 14728717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescent Colon and Breast Cancer Cells Induced by Doxorubicin Exhibit Enhanced Sensitivity to Curcumin, Caffeine, and Thymoquinone.
    El-Far AH; Darwish NHE; Mousa SA
    Integr Cancer Ther; 2020; 19():1534735419901160. PubMed ID: 32054357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenethyl caffeate benzo[kl]xanthene lignan with DNA interacting properties induces DNA damage and apoptosis in colon cancer cells.
    Vijayakurup V; Carmela S; Carmelo D; Corrado T; Srinivas P; Gopala S
    Life Sci; 2012 Dec; 91(25-26):1336-44. PubMed ID: 23123449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs.
    Chang BD; Xuan Y; Broude EV; Zhu H; Schott B; Fang J; Roninson IB
    Oncogene; 1999 Aug; 18(34):4808-18. PubMed ID: 10490814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.
    Matsui SI; Arredondo MA; Wrzosek C; Rustum YM
    Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of G2 arrest on the cytotoxicity of DNA topoisomerase inhibitors toward human carcinoma cells with different p53 status.
    Bozko P; Larsen AK; Raymond E; Skladanowski A
    Acta Biochim Pol; 2002; 49(1):109-19. PubMed ID: 12136930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts.
    Chen QM; Liu J; Merrett JB
    Biochem J; 2000 Apr; 347(Pt 2):543-51. PubMed ID: 10749685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cyclin A kinase activity in E2F-1 chemogene therapy of colon cancer.
    Elliott MJ; Baker JD; Dong YB; Yang HL; Gleason JF; McMasters KM
    Tumour Biol; 2002; 23(6):324-36. PubMed ID: 12677090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of econazole-induced toxicity on human colon cancer cells: G0/G1 cell cycle arrest and caspase 8-independent apoptotic signaling pathways.
    Ho YS; Wu CH; Chou HM; Wang YJ; Tseng H; Chen CH; Chen LC; Lee CH; Lin SY
    Food Chem Toxicol; 2005 Oct; 43(10):1483-95. PubMed ID: 15919146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe.
    Tse AN; Schwartz GK
    Cancer Res; 2004 Sep; 64(18):6635-44. PubMed ID: 15374978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells.
    Courage C; Snowden R; Gescher A
    Br J Cancer; 1996 Oct; 74(8):1199-205. PubMed ID: 8883405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aloe emodin induces G2/M cell cycle arrest and apoptosis via activation of caspase-6 in human colon cancer cells.
    Suboj P; Babykutty S; Srinivas P; Gopala S
    Pharmacology; 2012; 89(1-2):91-8. PubMed ID: 22343391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines.
    te Poele RH; Joel SP
    Br J Cancer; 1999 Dec; 81(8):1285-93. PubMed ID: 10604724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis.
    Park WH; Kim ES; Jung CW; Kim BK; Lee YY
    Int J Oncol; 2003 Feb; 22(2):377-82. PubMed ID: 12527937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.